Business Wire

RIVAC-INC.

7.8.2019 11:02:06 CEST | Business Wire | Press release

Share
RIVAC Inc. Has Released an iPhone App 'FrontShot' That Displays a Straight Frontal View of Any Plane in Real-Time Even If the Camera Is Pointed from an Oblique Direction

RIVAC Inc. has announced the release of an iPhone App 'FrontShot' that enables real-time display and shooting of a straight frontal view of any plane, even if the camera is pointed from an oblique direction. Operation is simple, and you can see a straight frontal view of any plane, such as a document or wall, through the camera.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190807005001/en/

Official website: https://www.english.rivac.co.jp

[Background of FrontShot development]
There are times when you want to shoot a straight frontal view of an object such as a document, wall, poster, or time-table. In cases like this, it is convenient if you can just point your camera from an oblique direction, and see the straight frontal view. FrontShot was developed to make this possible. Even if you point your camera from an oblique direction, any sort of plane —documents, walls, etc.— can be viewed as a straight frontal image.

[Features]
Has three modes: horizontal plane, vertical plane, and slanted plane.

- Can handle any plane
The app can handle not only horizontal and vertical planes, but also slanted planes, and thus it is possible to see a straight frontal view of any plane. Naturally, it is also possible to see straight frontal views of ceilings. (Ceilings are regarded as horizontal planes.)

- Simple operation
Operation is extremely simple. For a horizontal plane, no special operation is necessary. Simply point the camera, and the straight frontal image will appear. For a vertical or slanted plane, the orientation of the plane must be designated (automatically or manually), but if the mode is set to automatic, a straight frontal image will appear just by pointing the camera, as with a horizontal plane. Operation is simple in manual mode too. Just point the camera in the direction of the plane, and press the button. A straight frontal image of the plane will appear.

*In the automated mode for vertical and slanted planes, the system calculates the direction of the plane by recognizing the horizontal and vertical lines which appear.

- Display in real-time
Processing is performed at high speed using our unique technology, and this makes it possible to display straight frontal images in real-time.

[Uses]
The app can be used for a variety purposes including: documents, posters, whiteboards, time-tables, buildings, signs, pictures, lettering and pictures drawn on the ground, and online sale items (clothes, books, CDs, other flat items).

[App information]

App name

:

FrontShot

Device

:

iPhone (iOS9 or later)

Category

:

Photo & Video

Price

:

Check at the App Store. (A free trial is available. The product version can be purchased from the free version via in-app purchase.)

Released : August 5, 2019

iTunes URL

:

https://itunes.apple.com/app/id1434295595?mt=8

Official website

:

https://www.english.rivac.co.jp

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA® (levodopa inhalation powder) in Mainland China, Hong Kong and Macao26.5.2026 09:00:00 CEST | Press release

Kvvit to lead local development, regulatory activities and commercialization of INBRIJA® in mainland China, Hong Kong and Macao​ Under the agreement, Merz Therapeutics will receive upfront, development and commercial milestone payments, and tiered supply and royalty arrangements, with no manufacturing rights granted to Kvvit​ Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. today announced that the companies have entered into an exclusive license and collaboration agreement regarding INBRIJA® (levodopa inhalation powder) and its proprietary inhalation device for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson’s disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor in mainland China, Hong Kong and Macao.​ Under the agreement, Merz will supply INBRIJA® and retain responsibility for global product quality and key regulatory activities. Kvvit will lead development, regulatory activities and commercializat

Poland’s Poznan University of Technology Unveils IQM Quantum Computer to Drive Research and Education26.5.2026 08:49:00 CEST | Press release

IQM Radiance R1 is the first on-premises quantum computer for the PUT. The university aims to use the system to spearhead quantum education and research while boosting STEM in the country. This is the second operational quantum computer deployed in Poland by IQM. The university recognizes the significant long-term potential of integrating quantum computing, artificial intelligence, and high-performance computing (HPC), and intends to play a key role in shaping this transformation in Europe. Poznan University of Technology (PUT) has launched its first locally installed quantum computer, deployed by IQM Quantum Computers, to advance education and scientific research in the field of quantum technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525424085/en/ The moment Poland switched on IQM's second quantum computer. Minister of Science and Higher Education Dr. Marcin Kulasek, IQM CEO Jan Goetz and CCO Sylwia de Weyde

BearingPoint Introduces Fully Sovereign On-Premise Infrastructure for GenAI and Agentic AI in Europe26.5.2026 08:30:00 CEST | Press release

BearingPoint is expanding its AI portfolio with a fully owned, sovereign on-premise and edge infrastructure designed specifically for generative and agentic AI workloads in highly regulated industries and public administrations in Europe. Building on decades of experience operating its own sovereign cloud, the firm now offers clients both dedicated hardware and token-based access to large language models – fully GDPR-compliant, ISO-certified and, on request, NIS2- and DORA-ready BearingPoint announces the launch of the BearingPoint Fully-Owned Sovereign Infrastructure Stack, an infrastructure platform designed, operated, and managed entirely by BearingPoint for GenAI and agentic AI applications, consistently engineered for European sovereignty, compliance, and security. With its own data center in Graz, the solution enables companies and public institutions to run sensitive AI workloads in fully controlled, EU-based environments – from initial innovation projects to mission-critical sc

Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s26.5.2026 08:00:00 CEST | Press release

Study Topline results will be released around the end of Q2 2026 BIA 28-6156 is being developed as a potential first-in-class disease-modifying therapy in GBA-PD Bial was present at the GBA1 conference and is currently attending the World Parkinson Congress Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced the completion of the treatment period in its Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). Upon completion of the 78-week double-blind treatment period and all scheduled safety follow-ups, data cleaning and analysis are currently ongoing. Topline results will be released around the end of Q2. A status report on the ACTIVATE study was presented in an oral presentation at the 3rd International GBA1 Meeting 2026. The team is currently attending the 7th World Parkinson Congress, taking place in Pho

Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release

Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye